Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor - Wikidata - wikimedia - TriplyDB

Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor

Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor

http://www.wikidata.org/entity/Q36426142

about

Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.Membranous nephropathy: from models to man Primary glomerulonephritis: A review of important recent discoveries.Atypical anti-glomerular basement membrane disease.A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine.Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy.The role of complement in membranous nephropathy.Immunopathogenesis of membranous nephropathy: an update.Recurrent proliferative glomerulonephritis with monoclonal immunoglobulin G deposits leads to rapid graft loss after kidney transplantation: a case report.Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes.Membranous nephropathy in the kidney allograft.Monoclonal gammopathy of renal significance: Diagnostic workup.Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.PLA2R and THSD7A: Disparate Paths to the Same Disease?A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy.Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.Anti-Phospholipase A2 Receptor Autoantibody: A New Biomarker for Primary Membranous Nephropathy.Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues.Monoclonal gammopathy associated membranous glomerulonephritis: A rare entity.[Pathophysiology of extramembranous glomerulopathies. Fifty years of progress, from laboratory to patient].Membranous Glomerulopathy With Light Chain-Restricted Deposits: A Clinicopathological Analysis of 28 Cases.A New Classification System for IgG4 Autoantibodies.Pathogenetic role of glomerular CXCL13 expression in lupus nephritis.Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy

P2860

Q26747416-6D493871-9AB4-42D1-8315-642285D6C433 Q27023372-CDDE9EC0-DF88-4408-91B5-272012C04DB9 Q30276115-83EDC735-F17D-41C3-9D8C-1FBDE3BCF8EA Q33872569-3D0C6A18-173A-4937-80CE-BA788452C1CE Q36465902-D38F1A70-8AF7-4B4C-993B-FA909EB2BC9F Q36689172-69FDD185-3987-46FF-BC41-2F290287E033 Q36965127-52487F29-6CB0-4DBB-B624-D5BAD2862CA7 Q37670302-E2456A9B-F242-4AD0-9069-FB2D04E19BA5 Q38155652-9827FA6A-CAD1-4BDB-9C98-9C3204E2607C Q38203172-2F847D16-5732-447E-B470-48CE2F82F348 Q38783773-434C839A-F6B5-437B-8058-E9D711B12D94 Q38874091-F9910D0B-27F2-4C7B-84EB-B49D069B4A53 Q38959093-657E0BDF-979B-48AD-AC02-76DBDE7CCB2E Q39186665-F0759983-55F0-4380-A6FC-1CF7A41F9526 Q39251479-8A003AD8-205F-42ED-9545-E8606DEFAC99 Q39412533-6040C702-6864-43FC-910F-63CCEDF4BEC3 Q40054212-8E8D8EB3-96CC-4A2A-8779-D584EE9BC75B Q41709119-9F8431B2-C5D2-4356-A7B5-F771CC66E177 Q42286490-8E9B2AE1-0FE1-4A7A-B5CE-50EFA1064D6C Q42588842-A79F1937-BFA0-435D-8DBE-8EB956680495 Q43142215-9D3EA069-63CC-4841-A277-44F275A628FF Q46208311-9D2A5D8E-07FD-4B79-A729-8288A1403237 Q47108055-E60D6930-8D1F-4003-9602-29CC2E79AFDE Q50327901-6ECAC9AC-36E1-4043-A57F-A1FCA642EA74 Q51723759-95BEDA6B-5425-43AD-B86E-017D64EC691A Q52670774-CFDAEE63-2A74-4819-B12D-454B4750E282 Q58586428-FE71243D-BF7F-4DC6-A461-78CD9007ED8E

P2860

Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor

http://www.wikidata.org/entity/Q36426142

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Recurrent membranous nephropat ...... 3κ targeting the PLA2 receptor

@ast

Recurrent membranous nephropat ...... 3κ targeting the PLA2 receptor

@en

type

label

Recurrent membranous nephropat ...... 3κ targeting the PLA2 receptor

@ast

Recurrent membranous nephropat ...... 3κ targeting the PLA2 receptor

@en

prefLabel

Recurrent membranous nephropat ...... 3κ targeting the PLA2 receptor

@ast

Recurrent membranous nephropat ...... 3κ targeting the PLA2 receptor

@en

P1433

Q36426142-64EA7E0E-57A0-4C51-8AD2-A4220FD305F8

P1476

Q36426142-BAD8DEDD-8039-4615-AA9D-FB9D44A4F5B9

P2093

Q36426142-38B6542E-A58C-4954-AB67-B7E622A2E93E

Q36426142-5169D373-DE05-41B3-A8DD-E33D3D14A1AF

Q36426142-76C0A123-D59C-48A4-8108-5F33243EDFCF

Q36426142-A63796F6-4F05-47BA-A217-ADF9B5158E97

Q36426142-CB3E9BC7-B8F8-49CE-917A-4C648F6DC405

Q36426142-EAAF94FC-5777-49F9-B4E7-AC4F483FE053

Q36426142-EE3E3F22-7E12-4425-99DC-006A5B6BB340

Q36426142-F7F01B70-5551-4E16-9633-1BC42EA51DDC

Q36426142-FF8D124E-945E-459C-96D7-F14F3C16E0B9

P2860

Q36426142-0F2614FD-3751-4809-906D-DE71A786C464

Q36426142-1137CFCE-9B34-407A-B270-51C0399AA9B5

Q36426142-29519CF8-58CD-4E43-8D34-18571CD2E3AC

Q36426142-32F2B209-5D04-4C41-80D2-E51715E33216

Q36426142-629C1434-8F19-46B2-87A0-C68951B94D55

Q36426142-6E845EB1-FFA5-456B-BA61-563BD0319F4C

Q36426142-7D445508-BF53-458F-AD4B-6507033AAC84

Q36426142-806CD8F1-D879-42AD-80AF-A78BFBCE3077

Q36426142-8A2BD2FE-6CC1-41A6-8AD0-2C85FBF238D8

Q36426142-8FB0BAA5-508A-49C2-94AE-1E61A3DC406D

P304

Q36426142-DB0CCAFF-E09F-4A70-B074-C1E8400FC1CE

P31

Q36426142-76921637-8262-481e-8958-6a4f3620e3ff

Q36426142-D68460C5-95EA-4AB3-B056-7305072054A8

P356

Q36426142-E66A2DB5-F4BE-46D7-91FA-F80BCD869D71

P433

Q36426142-FD11E1C3-9DAD-4A35-A09B-3AEF56D14806

P478

Q36426142-A0729BFA-D0E3-4DB7-B708-2EE17A295D12

P577

Q36426142-84E8D019-338F-4205-A17D-E575F17952B5

P698

Q36426142-B250C061-56A7-45F9-B2F8-AEA3FE7AF7A2

P932

Q36426142-C513A709-C603-4926-BF14-EF1FCE42014E

P356

P1433

Journal of the American Society of Nephrology

P1476

Recurrent membranous nephropat ...... 3κ targeting the PLA2 receptor

@en

P2093

Arnaud Francois

http://www.w3.org/2001/XMLSchema#string

Catherine Johanet

http://www.w3.org/2001/XMLSchema#string

Dominique Guerrot

http://www.w3.org/2001/XMLSchema#string

Hanna Debiec

http://www.w3.org/2001/XMLSchema#string

Melanie Hanoy

http://www.w3.org/2001/XMLSchema#string

Michel Godin

http://www.w3.org/2001/XMLSchema#string

Pierre Aucouturier

http://www.w3.org/2001/XMLSchema#string

Pierre Ronco

http://www.w3.org/2001/XMLSchema#string

Sophie Ferlicot

http://www.w3.org/2001/XMLSchema#string

P2860

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.

Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease.

Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft.

Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy

Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization.

Experimental glomerulonephritis in the isolated perfused rat kidney

Proliferative glomerulonephritis with monoclonal IgG deposits.

P304

1949-1954

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2012060577

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23123401

http://www.w3.org/2001/XMLSchema#string

P932

3507371

http://www.w3.org/2001/XMLSchema#string